兽药市场规模、份额和成长分析（按产品类型、动物种类、给药途径、通路和地区划分）－2026-2033年产业预测

预计到 2024 年，全球动物医药市场规模将达到 541.3 亿美元，到 2025 年将达到 588.4 亿美元，到 2033 年将达到 1146.9 亿美元，预测期（2026-2033 年）的复合年增长率为 8.7%。

由于动物性蛋白质需求不断增长、通用感染疾病发病率上升以及创新产品的推出，全球动物医药市场正经历强劲增长。兽医技术的进步和宠物保险的日益普及进一步推动了该行业的发展。联邦政府资助的动物健康和福利项目的扩展，提高了消费者获得必要服务的途径，有助于改善动物福利和保障食品安全。这些努力有助于消除通用感染疾病，并促进永续农业实践。世界各国政府建立的法规结构，确保了动物用药品、疫苗和饲料添加剂的有效核准、生产和分销，并保证其安全性、有效性和质量，从而增强了消费者对动物保健产品的信任和信心。

推动全球动物医药市场发展的因素

全球动物医药市场的主要驱动力是专科药物、诊断技术和预防保健领域研发成本的不断上涨。这一趋势源于人们对宠物日益人性化的认知，以及饲主在宠物健康方面投入的不断增加。随着宠物获得更先进的治疗方案，例如疫苗、专科药物和健康管理计划，对这些产品的需求显着增长。为了满足这项需求，各公司正积极推动创新，例如生物製药、偏好的口服宠物饲主。

全球动物医药市场面临的限制因素

全球动物医药市场面临许多限制因素，其中生物製药和动物医药必须遵守严格的监管要求。这些法规因国家而异，其复杂性往往导致安全性和有效性评估的测试週期过长。这增加了研发成本，延长了产品上市时间。这种监管的不确定性通常对小规模公司不利，使它们难以参与竞争，并促使研发资源集中在大型公司手中。这阻碍了创新解决方案在农场和临床环境中的应用，尤其是在基因疗法和替代抗生素等领域。

全球动物医药市场趋势

全球动物医药市场正经历一场深刻的变革时期，而远端医疗和数位科技的融合正是这场变革的驱动力。远端医疗平台、远端监测解决方案和人工智慧驱动的决策支援工具等创新技术正在改变兽医服务的提供方式，尤其是在改善服务可及性和支援偏远农村地区的畜牧养殖户方面发挥着重要作用。数位化分诊和电子处方笺能够实现更积极主动的健康管理，而临床记录与预测分析相结合，则使兽医能够采用基于订阅的医疗服务模式。这种模式不仅能够提高依从性，还能创造稳定的收入来源，改善动物健康管理，并为更永续、更有效率的兽医实践铺路。

目录

介绍

• 调查目标
• 调查范围
• 定义

调查方法

• 资讯收集
• 二手资料和一手资料方法
• 市场规模预测
• 市场假设与限制

执行摘要

• 全球市场展望
• 供需趋势分析
• 细分市场机会分析

市场动态与展望

• 市场规模
• 市场动态
  • 驱动因素和机会
  • 限制与挑战
• 波特分析

关键市场考察

• 关键成功因素
• 竞争程度
• 关键投资机会
• 市场生态系统
• 市场吸引力指数（2025）
• PESTEL 分析
• 总体经济指标
• 价值链分析
• 定价分析
• 技术评估
• 监管环境

全球兽药市场规模（按产品类型和复合年增长率划分）（2026-2033 年）

• 製药
• 疫苗
• 药用饲料添加剂和补充剂
• 诊断和服务（辅助）

全球兽药市场规模（以动物类型划分）及复合年增长率（2026-2033 年）

• 伴侣动物（猫、狗、宠物）
• 生产/畜牧动物（牛、猪、家禽、水产养殖）
• 其他的

全球兽药市场规模（依给药途径及复合年增长率划分）（2026-2033 年）

• 注射
• 口服（锭剂、粉末）
• 外部/准确
• 饲料添加剂

全球兽药市场规模（依分销管道划分）及复合年增长率（2026-2033 年）

• 兽医医院和诊所
• 零售兽医诊所药房
• 网路药房
• 饲料厂/牲畜供应管道

全球兽药市场规模及复合年增长率（2026-2033）

• 北美洲
  • 美国
  • 加拿大
• 欧洲
  • 德国
  • 西班牙
  • 法国
  • 英国
  • 义大利
  • 其他欧洲地区
• 亚太地区
  • 中国
  • 印度
  • 日本
  • 韩国
  • 亚太其他地区
• 拉丁美洲
  • 巴西
  • 其他拉丁美洲地区
• 中东和非洲
  • 海湾合作委员会国家
  • 南非
  • 其他中东和非洲地区

竞争资讯

• 前五大公司对比
• 主要企业的市场定位（2025 年）
• 主要市场参与者所采取的策略
• 近期市场趋势
• 公司市占率分析（2025 年）
• 主要企业公司简介
  • 公司详情
  • 产品系列分析
  • 依业务板块进行公司股票分析
  • 2023-2025年营收年比比较

主要企业简介

• Zoetis Inc.
• Merck Animal Health（Merck & Co., Inc.）
• Boehringer Ingelheim GmbH（Animal Health）
• Elanco Animal Health Inc.
• Ceva Sante Animale SA
• Bayer AG（Animal Health division）
• Vetoquinol SA
• Nuproxa（or others）
• Virbac SA
• IDEXX Laboratories, Inc.
• Dechra Pharmaceuticals plc（Animal Health）
• Zoetis Pharmaceuticals Ltd.（companion unit）
• Kyoritsu Seiyaku Corporation（Veterinary）
• Huvepharma NV
• SK Biopharmaceuticals（Veterinary segment）
• Covetrus, Inc.
• Hester Biosciences Ltd.
• Kindred Biosciences, Inc.
• Qilu Animal Health Company Ltd.
• Vland Bioengineering Co., Ltd.

结论与建议

Global Veterinary Medicine Market size was valued at USD 54.13 Billion in 2024 and is poised to grow from USD 58.84 Billion in 2025 to USD 114.69 Billion by 2033, growing at a CAGR of 8.7% during the forecast period (2026-2033).

The global veterinary medicine market is experiencing robust growth driven by rising demand for animal protein, increasing instances of zoonotic diseases, and the introduction of innovative products. Advancements in veterinary practices, coupled with a growing trend in pet insurance, further support this sector. The expansion of federally funded animal health and wellness programs enhances consumer access to essential services, bolstering animal welfare and ensuring food supply safety. These initiatives lead to the culling of zoonotic pathogens and promote sustainable farming practices. Regulatory frameworks established by governments ensure the effective approval, production, and distribution of veterinary drugs, vaccines, and feed additives while guaranteeing their safety, efficacy, and quality, thereby fostering consumer trust and confidence in animal health products.

Top-down and bottom-up approaches were used to estimate and validate the size of the Global Veterinary Medicine market and to estimate the size of various other dependent submarkets. The research methodology used to estimate the market size includes the following details: The key players in the market were identified through secondary research, and their market shares in the respective regions were determined through primary and secondary research. This entire procedure includes the study of the annual and financial reports of the top market players and extensive interviews for key insights from industry leaders such as CEOs, VPs, directors, and marketing executives. All percentage shares split, and breakdowns were determined using secondary sources and verified through Primary sources. All possible parameters that affect the markets covered in this research study have been accounted for, viewed in extensive detail, verified through primary research, and analyzed to get the final quantitative and qualitative data.

Global Veterinary Medicine Market Segments Analysis

Global Veterinary Medicine Market is segmented by Product Type, Animal Type, Route of Administration, Distribution Channel and region. Based on Product Type, the market is segmented into Pharmaceuticals, Vaccines, Medicated Feed Additives & Supplements and Diagnostics & Services (supportive). Based on Animal Type, the market is segmented into Companion Animals (cats, dogs, pets), Production / Livestock Animals (cattle, swine, poultry, aquaculture) and Others. Based on Route of Administration, the market is segmented into Injectable, Oral (tablets, powders), Topical & Spot-On and Feed-Based Additives. Based on Distribution Channel, the market is segmented into Veterinary Hospitals & Clinics, Retail Veterinary Pharmacies, Online Pharmacies and Feed Mill / Livestock Supply Channels. Based on region, the market is segmented into North America, Europe, Asia Pacific, Latin America and Middle East & Africa.

Driver of the Global Veterinary Medicine Market

The Global Veterinary Medicine market is being significantly driven by the rising costs associated with the development of specialty medicines, diagnostics, and preventive care. This trend stems from the growing humanization of pets, leading owners to invest more in their animals' health. As pets increasingly receive advanced treatment options, including vaccines, specialty medications, and wellness programs, there is a noticeable surge in demand for these products. In response, companies are compelled to innovate, creating biologics and palatable oral medications, as well as subscription-based care models. Such advancements not only enhance revenue per patient but also strengthen the connection between pet owners and veterinary professionals.

Restraints in the Global Veterinary Medicine Market

The Global Veterinary Medicine market faces significant restraints due to the rigorous regulatory requirements that biologics and veterinary medicines must navigate, with these regulations differing across nations. This complexity often leads to protracted trial periods for assessing safety and efficacy, consequently increasing development costs and lengthening the time required to bring products to market. Such regulatory uncertainties tend to disadvantage smaller enterprises, causing them to struggle in competitive environments and causing research and development efforts to remain concentrated within larger corporations. As a result, the introduction of innovative solutions, particularly in areas like gene therapy and alternative antibiotics, is impeded in both farms and clinical settings.

Market Trends of the Global Veterinary Medicine Market

The Global Veterinary Medicine market is experiencing a significant shift propelled by the integration of telehealth and digital technologies. Innovations such as telemedicine platforms, remote monitoring solutions, and AI-driven decision-support tools are transforming veterinary care delivery, particularly benefiting underserved rural populations through enhanced accessibility. Digital triage and e-prescribing facilitate more proactive health management, while synchronized clinical records with predictive analytics empower veterinarians to implement subscription-based care models. This approach not only bolsters compliance but also generates reliable revenue streams, improving herd health management and paving the way for a more sustainable and efficient veterinary practice landscape.

Table of Contents

Introduction

• Objectives of the Study
• Scope of the Report
• Definitions

Research Methodology

• Information Procurement
• Secondary & Primary Data Methods
• Market Size Estimation
• Market Assumptions & Limitations

Executive Summary

• Global Market Outlook
• Supply & Demand Trend Analysis
• Segmental Opportunity Analysis

Market Dynamics & Outlook

• Market Overview
• Market Size
• Market Dynamics
  • Drivers & Opportunities
  • Restraints & Challenges
• Porters Analysis
  • Competitive rivalry
  • Threat of substitute
  • Bargaining power of buyers
  • Threat of new entrants
  • Bargaining power of suppliers

Key Market Insights

• Key Success Factors
• Degree of Competition
• Top Investment Pockets
• Market Ecosystem
• Market Attractiveness Index, 2025
• PESTEL Analysis
• Macro-Economic Indicators
• Value Chain Analysis
• Pricing Analysis
• Technology Assessment
• Regulatory Landscape

Global Veterinary Medicine Market Size by Product Type & CAGR (2026-2033)

• Market Overview
• Pharmaceuticals
• Vaccines
• Medicated Feed Additives & Supplements
• Diagnostics & Services (supportive)

Global Veterinary Medicine Market Size by Animal Type & CAGR (2026-2033)

• Market Overview
• Companion Animals (cats, dogs, pets)
• Production / Livestock Animals (cattle, swine, poultry, aquaculture)
• Others

Global Veterinary Medicine Market Size by Route of Administration & CAGR (2026-2033)

• Market Overview
• Injectable
• Oral (tablets, powders)
• Topical & Spot-On
• Feed-Based Additives

Global Veterinary Medicine Market Size by Distribution Channel & CAGR (2026-2033)

• Market Overview
• Veterinary Hospitals & Clinics
• Retail Veterinary Pharmacies
• Online Pharmacies
• Feed Mill / Livestock Supply Channels

Global Veterinary Medicine Market Size & CAGR (2026-2033)

• North America (Product Type, Animal Type, Route of Administration, Distribution Channel)
  • US
  • Canada
• Europe (Product Type, Animal Type, Route of Administration, Distribution Channel)
  • Germany
  • Spain
  • France
  • UK
  • Italy
  • Rest of Europe
• Asia Pacific (Product Type, Animal Type, Route of Administration, Distribution Channel)
  • China
  • India
  • Japan
  • South Korea
  • Rest of Asia-Pacific
• Latin America (Product Type, Animal Type, Route of Administration, Distribution Channel)
  • Brazil
  • Rest of Latin America
• Middle East & Africa (Product Type, Animal Type, Route of Administration, Distribution Channel)
  • GCC Countries
  • South Africa
  • Rest of Middle East & Africa

Competitive Intelligence

• Top 5 Player Comparison
• Market Positioning of Key Players, 2025
• Strategies Adopted by Key Market Players
• Recent Developments in the Market
• Company Market Share Analysis, 2025
• Company Profiles of All Key Players
  • Company Details
  • Product Portfolio Analysis
  • Company's Segmental Share Analysis
  • Revenue Y-O-Y Comparison (2023-2025)

Key Company Profiles

• Zoetis Inc.
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Merck Animal Health (Merck & Co., Inc.)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Boehringer Ingelheim GmbH (Animal Health)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Elanco Animal Health Inc.
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Ceva Sante Animale S.A.
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Bayer AG (Animal Health division)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Vetoquinol S.A.
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Nuproxa (or others)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Virbac S.A.
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• IDEXX Laboratories, Inc.
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Dechra Pharmaceuticals plc (Animal Health)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Zoetis Pharmaceuticals Ltd. (companion unit)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Kyoritsu Seiyaku Corporation (Veterinary)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Huvepharma NV
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• SK Biopharmaceuticals (Veterinary segment)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Covetrus, Inc.
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Hester Biosciences Ltd.
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Kindred Biosciences, Inc.
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Qilu Animal Health Company Ltd.
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Vland Bioengineering Co., Ltd.
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments

Conclusion & Recommendations